Pular para o conteúdo
Merck

900921

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

PEG average Mn 2,000, PLGA Mn 3,000, lactide:glycolide 50:50

Sinônimo(s):

PEG-PLGA, Polyethylene glycol, mPEG-b-PLGA

Slide 1 of 2
Faça login para ver os preços organizacionais e de contrato.

Selecione um tamanho

1 G

R$ 1.877,00

R$ 1.877,00

Verificar disponibilidade no carrinho
Peça uma encomenda em massa

Sobre este item

Fórmula linear:
H[(C3H4O2)x(C2H2O2)y]mO[C2H4O]nCH3
NACRES:
NA.23
UNSPSC Code:
51171641

Documentos Principais

Visualizar Toda a Documentação

Pular para

Assistência Técnica
Precisa de ajuda? Nossa equipe de cientistas experientes está à sua disposição.
Estamos aqui para ajudar

Nome do produto

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide), PEG average Mn 2,000, PLGA Mn 3,000, lactide:glycolide 50:50

form

crystals

feed ratio

lactide:glycolide 50:50

mol wt

PEG average Mn 2,000
PLGA Mn 3,000

impurities

≤5000 ppm (residual monomer by GC)

shipped in

dry ice

storage temp.

−20°C

Quality Level

100

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Comparar Itens Semelhantes

Ver Comparação Total

Mostrar diferenças

1 of 4

Este Item
913138911429911399
Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) PEG average Mn 2,000, PLGA Mn 3,000, lactide:glycolide 50:50

Sigma-Aldrich

900921

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) PEG average Mn 2,000, PLGA average Mn 10,000, lactide:glycolide 50:50

Sigma-Aldrich

913138

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) PEG average Mn 5,000, PLGA average Mn 5,000, lactide:glycolide 80:20

Sigma-Aldrich

911429

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) PEG average Mn 2,000, PLGA average Mn 10,000, lactide:glycolide 80:20

Sigma-Aldrich

911399

Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

form

crystals

form

powder or solid

form

powder

form

powder or chunks

Quality Level

100

Quality Level

100

Quality Level

-

Quality Level

100

mol wt

PEG average Mn 2,000, PLGA Mn 3,000

mol wt

PEG average Mn 2,000, PLGA average Mn 10,000 (by NMR)

mol wt

PEG average Mn 5,000 (by NMR), PLGA average Mn 5,000 (by NMR)

mol wt

PEG average Mn 2,000 (by NMR), PLGA average Mn 10,000 (by NMR)

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

impurities

≤5000 ppm (residual monomer by GC)

impurities

-

impurities

≤500 ppm (GC)

impurities

-

shipped in

dry ice

shipped in

-

shipped in

-

shipped in

-

Application

Biocompatible block copolymer can be used in the formation of nanoparticles for drug delivery. Potential use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents.

Classe de armazenamento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
MKCQ8183

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Miles A Miller et al.
Nature communications, 6, 8692-8692 (2015-10-28)
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their
Fabienne Danhier et al.
Journal of controlled release : official journal of the Controlled Release Society, 133(1), 11-17 (2008-10-28)
The purpose of this study was to develop Cremophor EL-free nanoparticles loaded with Paclitaxel (PTX), intended to be intravenously administered, able to improve the therapeutic index of the drug and devoid of the adverse effects of Cremophor EL. PTX-loaded PEGylated
Yihan Xu et al.
Journal of biomedical materials research. Part B, Applied biomaterials, 105(6), 1692-1716 (2016-04-22)
Poly (lactic-co-glycolic acid) (PLGA) copolymers have been broadly used in controlled drug release applications. Because these polymers are biodegradable, they provide an attractive option for drug delivery vehicles. There are a variety of material, processing, and physiological factors that impact
R Gref et al.
Science (New York, N.Y.), 263(5153), 1600-1603 (1994-03-18)
Injectable nanoparticulate carriers have important potential applications such as site-specific drug delivery or medical imaging. Conventional carriers, however, cannot generally be used because they are eliminated by the reticulo-endothelial system within seconds or minutes after intravenous injection. To address these

Questions

Reviews

No rating value

Active Filters

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica